Peter Jones

Peter Jones

Auto-generated profile, based on publicly available information

Peter Jones

Department of Surgery University of Auckland Auckland New Zealand

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2015 in Respiratory Care
Verified
Journal Article
Closed access
PDF file
PJPeter G Jones
Peter G Jones
SKSinan Kamona
Sinan Kamona
ODOwen Doran
Owen Doran
FSFrann Sawtell
Frann Sawtell
MWMargaret Wilsher
Margaret Wilsher
BACKGROUND: Humidified high-flow nasal cannula (HFNC) is a novel method of oxygen delivery with increasing use in emergency departments and intensive care settings despite little evidence showing benefit over standard oxygen delivery methods (standard O 2 ). The aim of this study was to determine whether HFNC compared with standard O 2 given to subjects in acute respiratory distress would reduce the need for noninvasive ventilation or invasive ventilation. METHODS: This was a pragmatic open randomized controlled trial in adult subjects with hypoxia and tachypnea presenting to a tertiary academic hospital emergency department. The primary outcome was the need for mechanical ventilation in the emergency department. RESULTS: We screened 1,287 patients, 322 met entry criteria and 19 were excluded from analysis. Of these, 165 randomized to HFNC and 138 to standard O 2 were analyzed. Baseline characteristics were similar. In the HFNC group, 3.6% (95% CI 1.5–7.9%) versus 7.2% (95% CI 3.8–13%) in the standard O 2 group required mechanical ventilation in the emergency department ( P = .16), and 5.5% (95% CI 2.8–10.2%) in HFNC versus 11.6% (95% CI 7.2–18.1%) in the standard O 2 group required mechanical ventilation within 24 h of admission ( P = .053). There was no difference in mortality or stay. Adverse effects were infrequent; however, fewer subjects in the HFNC group had a fall in Glasgow coma score due to CO 2 retention, 0% (95% CI 0–3%) versus 2.2% (95% CI 0.4–6%). One in 12 subjects did not tolerate HFNC. CONCLUSIONS: HFNC was not shown to reduce the need for mechanical ventilation in the emergency department for subjects with acute respiratory distress compared with standard O 2 , although it was safe and may reduce the need for escalation of oxygen therapy within the first 24 h of admission.

29 September 2010 in Emergency Medicine Australasia
Verified
Journal Article
Closed access
PDF file
PJPeter Jones
Peter Jones
KSKaren Schimanski
Karen Schimanski

3 September 2014 in Emergency Medicine Australasia
Verified
Journal Article
Closed access
PDF file
JWJordon Wimsett
Jordon Wimsett
AHAlana Harper
Alana Harper
PJPeter Jones
Peter Jones

1 July 2002 in European Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
HZHolger Zitt
Holger Zitt
IDIna Dix
Ina Dix
HHHenning Hopf
Henning Hopf
PJPeter G. Jones
Peter G. Jones

10 February 2020 in Emergency Medicine Australasia
Verified
Journal Article
Open access
PDF file
GKGerben Keijzers
Gerben Keijzers
SMStephen Macdonald
Stephen Macdonald
AUAndrew A Udy
Andrew A Udy
GAGlenn Arendts
Glenn Arendts
MBMichael Bailey
Michael Bailey
TGthe ARISE FLUIDS Observational Study Group
the ARISE FLUIDS Observational Study Group
Objectives: To describe haemodynamic resuscitation practices in ED patients with suspected sepsis and hypotension.Methods: This was a prospective, multicentre, observational study conducted in 70 hospitals in Australia and New Zealand between September 2018 and January 2019. Consecutive adults presenting to the ED during a 30‐day period at each site, with suspected sepsis and hypotension (systolic blood pressure <100 mmHg) despite at least 1000 mL fluid resuscitation, were eligible. Data included baseline demographics, clinical and laboratory variables and intravenous fluid volume administered, vasopressor administration at baseline and 6‐ and 24‐h post‐enrolment, time to antimicrobial administration, intensive care admission, organ support and in‐hospital mortality.Results: A total of 4477 patients were screened and 591 were included with a mean (standard deviation) age of 62 (19) years, Acute Physiology and Chronic Health Evaluation II score 15.2 (6.6) and a median (interquartile range) systolic blood pressure of 94 mmHg (87–100). Median time to first intravenous antimicrobials was 77 min (42–148). A vasopressor infusion was commenced within 24 h in 177 (30.2%) patients, with noradrenaline the most frequently used (n = 138, 78%). A median of 2000 mL (1500–3000) of intravenous fluids was administered prior to commencing vasopressors. The total volume of fluid administered from pre‐enrolment to 24 h was 4200 mL (3000–5661), with a range from 1000 to 12 200 mL. Two hundred and eighteen patients (37.1%) were admitted to an intensive care unit. Overall in‐hospital mortality was 6.2% (95% confidence interval 4.4–8.5%).Conclusion: Current resuscitation practice in patients with sepsis and hypotension varies widely and occupies the spectrum between a restricted volume/earlier vasopressor and liberal fluid/later vasopressor strategy.

7 April 2014 in Emergency Medicine Australasia
Verified
Journal Article
Closed access
PDF file
PJPeter Jones
Peter Jones
MSMichael Shepherd
Michael Shepherd
SWSusan Wells
Susan Wells
JFJames Le Fevre
James Le Fevre
SAShanthi Ameratunga
Shanthi Ameratunga